Kamada (KMDA) Other financing activities (2013 - 2026)

Kamada (KMDA) posted quarterly Other financing activities of -$467000.0 for Q1 2026, down 43.69% year-on-year from -$829371.6 in Q1 2025, and up 55.14% on a QoQ basis from -$1.0 million in Q4 2025.

Kamada (KMDA) Other financing activities (2013 - 2026) Analysis & Trends

Kamada (KMDA) has reported Other financing activities for 10 consecutive years, with -$467000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Other financing activities fell 43.69% year-over-year to -$467000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.0 million (up 19.54% YoY) and the FY2025 annual result came in at -$5.9 million, up 53.51% from the prior year.
  • Other financing activities improved to -$467000.0 in Q1 2026 per KMDA's latest filing, from -$1.0 million in the prior quarter.
  • Over the last five years, Other financing activities for KMDA reached as high as -$877.0 in Q3 2022 and fell as low as -$11.5 million in Q3 2023.
  • A 5-year average of -$2.4 million and a median of -$1.5 million in 2022 frame the typical range for Other financing activities.
  • The largest YoY upside for Other financing activities was 99.9% in 2023 against a maximum downside of 1311188.48% in 2023.
  • Year by year, Other financing activities stood at -$1.5 million in 2022, then rose by 0.4% to -$1.5 million in 2023, then jumped by 76.6% to -$351000.0 in 2024, then sank by 196.58% to -$1.0 million in 2025, then surged by 55.14% to -$467000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered -$467000.0, -$1.0 million, and -$339000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -467,000.00
Mar 31, 2026 -467,000.00
Dec 31, 2025 -1.04 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 -339,000.00
Sep 30, 2025 -339,000.00
Jun 30, 2025 -4.18 Mn
Jun 30, 2025 -4.18 Mn
Mar 31, 2025 -325,000.00
Mar 31, 2025 -325,000.00
Dec 31, 2024 -351,000.00
Dec 31, 2024 -351,000.00
Sep 30, 2024 -4.47 Mn
Sep 30, 2024 -4.47 Mn
Jun 30, 2024 -2.35 Mn
Jun 30, 2024 -2.35 Mn
Mar 31, 2024 -5.50 Mn
Mar 31, 2024 -5.50 Mn
Dec 31, 2023 -1.50 Mn
Dec 31, 2023 -1.50 Mn